This book addresses the unique considerations of applying pharmacogenomics in pediatric populations. It explores how genetic differences influence drug metabolism, efficacy, and safety in children. The text emphasizes the importance of age-specific genetic markers for optimizing pediatric treatments. Ideal for pediatricians and pharmacogenomic researchers, it promotes safer and more effective drug therapies for young patients.
Benjamin Stewart specializes in pharmacogenomics within pediatric dermatology, focusing on optimizing treatments for children based on their genetic profiles. His research explores how genetic variations affect the response to medications used in managing pediatric skin conditions like atopic dermatitis and acne. Benjamin has authored numerous studies on personalizing pediatric dermatological therapies to enhance safety and efficacy through pharmacogenomic testing. He also offers guidelines for clinicians to incorporate pharmacogenomic insights into pediatric dermatological care, promoting safe and effective personalized treatments for young patients through genetic-informed approaches.